Dolores G Roco

The committee meeting featured an update from the Department of Cannabis Control Director regarding the department's strategic goals, which include ensuring safe products, exerting pressure on the illicit market, increasing access to legal retail options, and reducing friction for licensees. Additionally, public comments were heard concerning the potential negative impact of marijuana advertising on youth and concerns regarding a state assembly bill that could allow drive-thru sales at cannabis storefronts. Committee members also discussed potential collaboration between the Department of Cannabis Control and agricultural commissioners regarding pesticide regulation and enforcement.

The committee meeting addressed several key topics concerning public health and regulatory issues related to cannabis. Discussions focused on the impact of cannabis advertising, particularly large-format billboards near schools and neighborhoods, and concerns regarding dispensary clustering. Public commenters urged for stricter regulations to protect youth from exposure to cannabis marketing and high-potency products. Additionally, the committee discussed the adoption of their annual report.

The primary discussion topic for the meeting materials concerns the batch tagging of mature cannabis plants, following recent statutory changes that allow for tagging larger quantities of mature plants under a single tag, moving away from the current requirement for individual tagging. The committee is requested to provide input on potential structures for batch tagging (e.g., by number, strain, or row), appropriate limitations, desirability for cultivators, regulatory pros and cons, and considerations related to the existing Metrc contract costs and future hemp integration by 2028. The Department is also seeking data points related to tagging timeframes and harvest time averages.

The meeting included discussions on various topics such as the cost of cannabis licensing, potential toxicity of metric tags, reassessing licensing fees, the need for a testing lab representative on the committee, potency inflation, conflicts between state cannabis regulations and local control, issues with dual products, problems with metric submissions, and the risks of cannabis use during pregnancy.

The Cannabis Advisory Committee held a meeting to discuss several key issues. The committee approved the minutes from the previous meeting. A motion was passed to remove the cap on the number of products and eliminate limitations on product types, with a recommendation for further discussion with the DCC after these changes are implemented. The committee also recommended the implementation of SB 1064. Future discussion items include batch tagging of cannabis plants, youth programs, and tax allocations toward youth programs.